HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Yi Chen Selected Research

Type II DNA Topoisomerases (Topoisomerase II)

7/2014Selective cellular uptake and retention of SN 28049, a new DNA-binding topoisomerase II-directed antitumor agent.
11/2013Tumour tissue selectivity in the uptake and retention of SN 28049, a new topoisomerase II-directed anticancer agent.
12/2011In vivo and in vitro assessment of the action of SN 28049, a benzonaphthyridine derivative targeting topoisomerase II, on the murine Colon 38 carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Yi Chen Research Topics

Disease

2Carcinoma (Carcinomatosis)
07/2014 - 12/2011
1Adenocarcinoma of Lung
01/2021
1Poisoning
11/2013
1Adenocarcinoma
12/2011

Drug/Important Bio-Agent (IBA)

3N- (2- (dimethylamino)ethyl)- 2,6- dimethyl- 1- oxo- 1,2- dihydroxybenzo(b)- 1,6- naphthyridine- 4- carboxamideIBA
07/2014 - 12/2011
3Type II DNA Topoisomerases (Topoisomerase II)IBA
07/2014 - 12/2011
2DNA (Deoxyribonucleic Acid)IBA
07/2014 - 12/2011
1AcridinesIBA
01/2021
1PoisonsIBA
07/2014
1EnzymesIBA
11/2013
1Etoposide (VP 16)FDA LinkGeneric
12/2011